Summary
Highlights
The video introduces macrocytic anemias, characterized by an MCV greater than 100. These can be subdivided into megaloblastic and non-megaloblastic anemias, with megaloblastic anemias resulting from nuclear deficits, often due to issues in DNA synthesis or repair. Orotic aciduria falls under issues with DNA synthesis.
Orotic aciduria is an autosomal recessive disorder caused by a problem with de novo pyrimidine synthesis. Specifically, it involves a deficiency in the enzyme uridine monophosphate synthase (UMP synthase), which is crucial for converting orotic acid to UMP. This deficiency leads to low levels of UMP, thymine, and cytosine, and high levels of orotic acid.
Key findings include macrocytic megaloblastic anemia due to decreased DNA synthesis, hypersegmented neutrophils (which cannot mature properly due to defective DNA synthesis), and orotic acid crystals in the urine. Unlike other megaloblastic anemias, it does not involve hyperammonemia and does not improve with folate or vitamin B12 supplementation. Patients may also experience failure to thrive and developmental delays.
Orotic aciduria is often a diagnosis of exclusion, considered when macrocytic megaloblastic anemia does not respond to folate or vitamin B12. The treatment involves administering UMP or uridine triacetate, which bypasses the deficient UMP synthase. This treatment addresses the anemia, hypersegmented neutrophils, and failure to thrive, but orotic acid crystals in the urine will still persist.